DCGI approves study on mixing of Covishield and Covaxin in India

Updated : Aug 11, 2021 07:58
|
Editorji News Desk

The Drugs Controller General of India (DCGI) has given its approval for a study on mixing of Covaxin and Covishield Covid-19 vaccines in India. This study and its clinical trials will be conducted by Christian Medical College, Vellore.

On July 29, a Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had recommended conducting this study. In its meeting, the expert committee granted permission to CMC, Vellore for conducting the Phase-4 clinical trial covering 300 healthy volunteers, for mixing of Covid-19 vaccines Covaxin and Covishield.

The purpose of this study is to assess whether a person can be given two different vaccine shots -- one each of Covishield and Covaxin -- to complete the vaccination course.

Also watch: Explained: Should you mix and match 2 different Covid-19 vaccines?

The Indian Council of Medical Research in a separate study said mixing doses of Covaxin and Covishield have shown better results in building immunity against the virus causing Covid-19.

Also watch: Mixing and matching of Covaxin and Covishield shows better results: ICMR

COVAXINCOVISHIELDDCGICovid 19

Recommended For You

editorji | India

Editorji Launches Hook Global, Its International Digital News Brand

editorji | India

'Operation Tiger is complete,' roars Shinde as 6 Uddhav MPs join his Sena; calls them Dhurandhar

editorji | India

Kashmiri Pandits should move on, stop being prisoners of past: Mehbooba

editorji | India

At least 15 dead as fire rips through Lucknow building, students among victims

editorji | India

SC seeks responses of Centre, States on plea for use of Aadhaar as identity proof only